Concepedia

A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma

Hui Xie, Shengtao Tian, Haipeng Yu, Xueling Yang, Jia Liu, Huaming Wang, Fan Feng

OncoTargets and Therapy · 2018 · 51 citations · 27 references

DOIFull text

Open access

Abstract

Based on these results, we conclude that Apa-MS, a slow releasing system of apatinib, allows apatinib to remain effective in tumor tissues for a long time and could enhance the antitumor effect of RFA on HCC.

References

27

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

Jordi Bruix, Shukui Qin, Philippe Merle et al. · The Lancet · 2016 · 3.6K citations · Full text

, , +8

Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma

Chunping Wang, Huaming Wang, Wuwei Yang et al. · Hepatology · 2014 · 278 citations

miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect

Ling Li, Lei Kang, Wei Zhao et al. · Cancer Letters · 2017 · 225 citations

, , +10

Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents

Hui Jia, Qian Yang, Tao Wang et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2016 · 111 citations

, , +9

Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma

Fan Feng, Qiyu Jiang, Shuang Cao et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2018 · 105 citations

, , +8